u/meera_sandvik

Not convinced.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Not to be pedantic but COA and area percent are being used interchangeably and they are not interchangeable in real life.

Strongly agree. The supply impact would be huge.

Half-life is about 168 hours, so steady state lands around week 2–5. Practical consequence: what you feel in week 1 is not what that dose does.

glucagon co-agonism has a different safety story

testing the vendor claim versus testing your actual vial are two different posts

This is correct. ATTAIN data is phase 13.

This is the "correlation is mechanism" thing again. You changed three variables at once.

the small molecule is whether this actually works long-term

Adding to this: non-peptide is doing more work than the comment implies.

cite ATTAIN/ACHIEVE arms specifically

the vial you ordered versus the vial you received might be different batches

Retitled to remove editorialising.

Adding to this: ice pack is doing more work than the comment implies.

the logger trace is the data that matters, not the packaging promises

Australia to Australia: 17 days with SSA and 26 days with GGPeps. Same route, different carriers, variance is real.

customs clearance often breaks the cold chain, factor that in

the reship offer that never sends anything is worth noting

Was that the vendor COA or your own test?

excursion claims need a logger trace or a photo at unboxing, not "it felt warm"

This is the correct framing. The COA structure matters as much as the number.